Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
got her 1st dose of Twinrix on 7/1/2024...she is scheduled coming today; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on 01-JUL-2024, batch number:H7RF72 and expiry date:17-JAN-2026). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: got her 1st dose of Twinrix on 7/1/2024...she is scheduled coming today). The outcome of the incomplete course of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-JAN-2025 The reporter called to inform that they had a patient, she got her 1st dose of Twinrix on 7th January 2024 and she was scheduled coming at the time of reporting for the 2nd dose, she's long overdue. Did not consent to follow-up. Till the time of reporting, the patient did not receive the 2nd dose of Twinrix, which led to incomplete course of vaccination.